Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

June 10, 2025

Study Completion Date

June 10, 2026

Conditions
Cholangiocarcinoma Non-resectableNon-metastatic
Interventions
DRUG

Gemcitabine-Oxaliplatin Regimen

"Vascularisation of hepatic tumors is almost exclusively provided by the hepatic artery.~Gemcitabine and oxaliplatin have a high rate of hepatic extraction during the first passage, thus allowing the drugs to reach high intra-tumoral concentrations with low systemic toxicity."

PROCEDURE

Hepatic intra arterial chemotherapy

"The implantation of a hepatic arterial catheter has now been mastered by interventional radiologists and makes it possible to increase the intra-tumoral concentration of the drugs and probably to limit their systemic toxicity.~Very recently, we have reported that this combination in progressive IHC following systemic gemcitabine/oxaliplatin has led to partial responses and allowed certain patients to benefit from curative treatment.~This suggests that the intra-arterial approach increases the efficacy of these 2 drugs. For locally-advanced IHC, such a loco-regional approach is worth exploring in this poor-prognosis tumor."

Trial Locations (7)

34295

RECRUITING

Uhmontpellier, Montpellier

Unknown

RECRUITING

Amiens University Hospital, Amiens

RECRUITING

Angers University Hospital, Angers

RECRUITING

Bordeaux University Hospital, Bordeaux

RECRUITING

Centre Georges François Leclerc, Dijon

RECRUITING

Hôpital Européen Georges Pompidou, Paris

RECRUITING

Institut Gustave Roussy, Villejuif

All Listed Sponsors
collaborator

Federation Francophone de Cancerologie Digestive

OTHER

lead

University Hospital, Montpellier

OTHER